84 related articles for article (PubMed ID: 25023625)
21. The role of naïve T-cells in HIV-1 pathogenesis: an emerging key player.
Khoury G; Rajasuriar R; Cameron PU; Lewin SR
Clin Immunol; 2011 Dec; 141(3):253-67. PubMed ID: 21996455
[TBL] [Abstract][Full Text] [Related]
22. HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control.
Yue FY; Lo C; Sakhdari A; Lee EY; Kovacs CM; Benko E; Liu J; Song H; Jones RB; Sheth P; Chege D; Kaul R; Ostrowski MA
J Immunol; 2010 Jul; 185(1):498-506. PubMed ID: 20519650
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
Körner C; Tolksdorf F; Riesner K; Krämer B; Schulte D; Nattermann J; Rockstroh JK; Spengler U
Antivir Ther; 2011; 16(7):1047-55. PubMed ID: 22024520
[TBL] [Abstract][Full Text] [Related]
24. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection.
Fan J; Bass HZ; Fahey JL
J Immunol; 1993 Nov; 151(9):5031-40. PubMed ID: 8409454
[TBL] [Abstract][Full Text] [Related]
25. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes.
Huang J; Wang F; Argyris E; Chen K; Liang Z; Tian H; Huang W; Squires K; Verlinghieri G; Zhang H
Nat Med; 2007 Oct; 13(10):1241-7. PubMed ID: 17906637
[TBL] [Abstract][Full Text] [Related]
26. Despite an impaired response to IL-7, CD4+EM T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI.
Pacheco Y; Solé V; Billaud E; Allavena C; Plet A; Ferré V; Garrigue-Antar L; Raffi F; Jacques Y; McIlroy D
AIDS; 2011 Sep; 25(14):1701-10. PubMed ID: 21673554
[TBL] [Abstract][Full Text] [Related]
27. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
[TBL] [Abstract][Full Text] [Related]
28. High IL-7 plasma levels may induce and predict the emergence of HIV-1 virulent strains in pediatric infection.
Kopka J; Mecikovsky D; Aulicino PC; Mangano AM; Rocco CA; Bologna R; Sen L
J Clin Virol; 2005 Jul; 33(3):237-42. PubMed ID: 15911446
[TBL] [Abstract][Full Text] [Related]
29. [CD160 characterization and its association with disease progression in patients with chronic HIV-1 infection].
Wang L; Xu X; Feng G; Zhang X; Wang F
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1559-62. PubMed ID: 25146744
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs and exosomes: key players in HIV pathogenesis.
Sadri Nahand J; Bokharaei-Salim F; Karimzadeh M; Moghoofei M; Karampoor S; Mirzaei HR; Tabibzadeh A; Jafari A; Ghaderi A; Asemi Z; Mirzaei H; Hamblin MR
HIV Med; 2020 Apr; 21(4):246-278. PubMed ID: 31756034
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs and their potential involvement in HIV infection.
Sun G; Rossi JJ
Trends Pharmacol Sci; 2011 Nov; 32(11):675-81. PubMed ID: 21862142
[TBL] [Abstract][Full Text] [Related]
32. miR-155 is differentially expressed in Treg subsets, which may explain expression level differences of miR-155 in HIV-1 infected patients.
Seddiki N; Swaminathan S; Phetsouphanh C; Kelleher AD
Blood; 2012 Jun; 119(26):6396-7. PubMed ID: 22745300
[No Abstract] [Full Text] [Related]
33. Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection.
Gibson MS; Noronha-Estima C; Gama-Carvalho M
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205318
[TBL] [Abstract][Full Text] [Related]
34. Editorial overview: cell dysfunction and exhaustion in HIV infection.
Seddiki N; Kaufmann DE
Curr Opin HIV AIDS; 2014 Sep; 9(5):437-8. PubMed ID: 25023624
[No Abstract] [Full Text] [Related]
35. Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors.
Egaña-Gorroño L; Escribà T; Boulanger N; Guardo AC; León A; Bargalló ME; Garcia F; Gatell JM; Plana M; Arnedo M;
PLoS One; 2014; 9(9):e106360. PubMed ID: 25225963
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients.
Monteleone K; Selvaggi C; Cacciotti G; Falasca F; Mezzaroma I; D'Ettorre G; Turriziani O; Vullo V; Antonelli G; Scagnolari C
BMC Infect Dis; 2015 Feb; 15():51. PubMed ID: 25808800
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-155 Reinforces HIV Latency.
Ruelas DS; Chan JK; Oh E; Heidersbach AJ; Hebbeler AM; Chavez L; Verdin E; Rape M; Greene WC
J Biol Chem; 2015 May; 290(22):13736-48. PubMed ID: 25873391
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro.
Reynoso R; Laufer N; Hackl M; Skalicky S; Monteforte R; Turk G; Carobene M; Quarleri J; Cahn P; Werner R; Stoiber H; Grillari-Voglauer R; Grillari J
Sci Rep; 2014 Aug; 4():5915. PubMed ID: 25081906
[TBL] [Abstract][Full Text] [Related]
39. Interplay between microRNAs, Toll-like receptors, and HIV-1: potential implications in HIV-1 replication and chronic immune activation.
Swaminathan G; Navas-Martín S; Martín-García J
Discov Med; 2014; 18(97):15-27. PubMed ID: 25091485
[TBL] [Abstract][Full Text] [Related]
40. Novel HIV-1 miRNAs stimulate TNFα release in human macrophages via TLR8 signaling pathway.
Bernard MA; Zhao H; Yue SC; Anandaiah A; Koziel H; Tachado SD
PLoS One; 2014; 9(9):e106006. PubMed ID: 25191859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
